Global Recognition Leverage multiple high-profile awards and media coverage (Edison Silver, TIME Best Inventions, Fast Company Most Innovative Companies, Deloitte Fast 500) to credential the Quantra Hemostasis System in procurement conversations and patient-safety narratives.

Maternal Health Focus Highlight the system’s relevance to obstetric procedures and maternal bleeding management to target hospitals and health systems prioritizing obstetrics, maternal care programs, and peripartum bleeding protocols.

Point-of-Care Advantage Emphasize rapid, cartridge-based viscoelastic testing at the bedside to hospitals seeking faster decision-making in perioperative and emergency settings, reducing turnaround times and enabling protocol-driven care.

Strategic Partnerships Position HemoSonics for procurement partnerships with larger health systems and Premier/IDN networks, tapping into award-driven credibility and the company’s supplier-focused recognition to win contracts and favorable terms.

Growth Profile Leverage the company’s funding level and mid-size scale to pursue strategic pilots, expand into adjacent surgical specialties, and build case studies demonstrating improved outcomes and cost-per-use advantages.